Cleared Traditional

K251422 - BD Saf-T-Intima™ Subcutaneous Catheter System (FDA 510(k) Clearance)

Oct 2025
Decision
154d
Days
Class 2
Risk

K251422 is an FDA 510(k) clearance for the BD Saf-T-Intima™ Subcutaneous Catheter System. This device is classified as a Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (Class II - Special Controls, product code FOZ).

Submitted by Becton Dickinson Infusion Therapy Systems, Inc. (Sandy, US). The FDA issued a Cleared decision on October 8, 2025, 154 days after receiving the submission on May 7, 2025.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5200.

Submission Details

510(k) Number K251422 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 2025
Decision Date October 08, 2025
Days to Decision 154 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code FOZ — Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5200

Similar Devices — FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 13
BD Nexiva™ Closed IV Catheter System
K243403 · Becton Dickinson Infusion Therapy Systems, Inc. · Jul 2025
BD Cathena™ Safety IV Catheter
K251155 · Becton Dickinson Infusion Therapy Systems, Inc. · Jul 2025
BD Insyte™ Autoguard™ Shielded IV Catheter, BD Insyte™ Autoguard™ BC Shielded IV Catheter and BD Insyte™ Autoguard™ BC Pro Shielded IV Catheter
K251654 · Becton Dickinson Infusion Therapy Systems, Inc. · Jun 2025
BD Nexiva™ Diffusics™ Closed IV Catheter System and BD Nexiva™ Diffusics™ Closed IV Catheter System with BD MaxZero™ Needle-free Connector
K250682 · Becton Dickinson Infusion Therapy Systems, Inc. · Jun 2025
Introcan Safety® 2 IV Catheter
K241845 · B.Braun Medical, Inc. · Jul 2024
BD Nexiva™ Diffusics™ Closed IV Catheter System with BD MaxZero™ Needle-free Connector
K233529 · Becton Dickinson Infusion Therapy Systems, Inc. · Dec 2023